Topics
High-grade gliomas | Treatment | Targeted therapy | Apatinib
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Apatinib
Chen Z, Guo C, Yang Q, Lin F, Hu W,
Xi S, Zhang J, Jiang X, Li D, Chen Y, Ke C,
Zhou J, Zhou Z, Ceng S.
AB048.
Evidence of effectiveness of neoadjuvant
camrelizumab
and apatinib in patients with recurrent high-grade gliomas.
Chin
Clin
Oncol. 2024 Aug
30;13(Suppl 1):AB048. doi:
10.21037/cco-24-ab048. PMID:
39295366. Interventional
study. ˍ
Cai L, Feng J, Li X, Ying W, Li G, Luo H, Wang X, Wu M, Fu Z.
Postoperative
concurrent chemoradiotherapy plus
apatinib for patients with high-grade glioma:
a retrospective cohort study.
Chin
Clin Oncol. 2024 Dec 31;13(6):82. doi:
10.21037/cco-24-51. PMID:
39806848. Observational study. ˍ